SIGN UP
LOG IN
I
ITCI
Intra-Cellular Therapies
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Benzinga·04/02 22:01
Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews
Dow Jones·04/02 21:08
*News On Intra-Cellular Therapies Inc. (ITCI) Now Under JNJ
TipRanks·04/02 20:30
Intra-Cellular Therapies Completes Merger with Johnson & Johnson
Benzinga·04/02 16:26
Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended
TipRanks·04/02 12:56
Intra-Cellular Therapies (ITCI) Receives a Rating Update from a Top Analyst
NASDAQ·04/01 10:20
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
Seeking Alpha·03/27 11:30
Franklin Biotechnology Discovery Fund Q4 2024 Commentary
Reuters·03/26 20:16
Jefferies profit falls on weaker bond trading, equity underwriting
Barchart·03/24 06:46
Here's How to Play JNJ Stock as it Announces $55B US Investment Plan
Seeking Alpha·03/21 19:00
Catalyst Watch: CoreWeave IPO, Dollar Tree earnings, Newsmax pricing, and GameStop crypto intrigue
Seeking Alpha·03/20 15:20
Defensive Stocks For Unpredictable Trump Policy
Reuters·03/18 21:25
INTRA-CELLULAR THERAPIES INC - BELIEVES LAWSUIT CLAIMS ARE WITHOUT MERIT
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.